“…The majority of previous antiviral studies have reported the use of knockdown of baculovirus DNA replication factor immediate early‐1 (IE‐1) gene through RNAi technology, which significantly inhibited the virus replication in vivo and in vitro (Zhang, Wang et al , ; Zhou et al , ). Moreover, ie‐1 , lef‐1 , lef‐2 , lef‐3 , lef‐11 , oral infection factor p74 and gp64 have also significantly inhibited virus multiplication and replication in transgenic cells and silkworm (Fujita et al , ; Jiang et al , ; Xu et al , ; Zhang, He et al , ; Zhou et al , ; Cao et al , ). However, baculovirus early transcription activator and DNA replication factors, ie‐0 and ie‐2 , have not yet been studied as target genes.…”